A.T.S. Pharmaceuticals A division of Auriga Laboratories, Inc. Launches XyralidTM LP Lotion

LOS ANGELES--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and xerostomia, announced today the launch of Xyralid™ LP Lotion (lidocaine HCl 3%/hydrocortisone acetate 0.5%) convenience kit that also contains Clere™, a soap free cleanser. Xyralid LP Lotion will be promoted to Dermatologists, Gastroenterologists and Primary Care Practitioners by the A.T.S. Pharmaceutical division.